Analysis of a differential equation model of HIV infection of $CD4^+$T -cells with saturated reverse function

Analysis of a differential equation model of HIV infection of $CD4^+$T -cells with saturated reverse function

In this paper, an ordinary differential equation model of HIV infection of $CD4^ + $ T-cells with saturated reverse function is studied. We prove that if the basic reproduction number $R_0 < 1$, the virus-free equilibrium is locally asymptotically stable. And there will exhibit backward bifurcation when $R_0 < 1$. If $R_0 > 1$, some feasibly sufficient conditions are obtained for the global asymptotic stability of a positive equilibrium of the model by using the theory of competitive systems, compound matrices and stability of periodic orbits. Furthermore, we also obtain the conditions for which the model exists an orbitally asymptotically stable periodic solution. Numerical simulations are presented to illustrate the results.

___

  • [1] Brauer, F.: Backward bifurcations in simple vaccination models, J. Math. Anal. Appl. 298, 418–431 (2004).
  • [2] De Boer, R.J., Perelson, A.S.: Target cell limited and immune control models of HIV infection: A comparison, J. Theoret. Biol. 190, 201–214 (1998).
  • [3] Essunger, P., Perelson, A.S.: Modeling HIV infection of CD4 T-cell subpopulations, J. Theor. Biol. 170, 367–391 (1994).
  • [4] Gantmacher, F.R.: The Theory of Matrices, Chelsea Publ. Co., New York, 1959.
  • [5] Hirsch, M.W.: Systems of differential equations which are competitive or cooperative, IV, SIAM J. Math. Anal. 21, 1225–1234 (1990).
  • [6] Kepler, T.B., Perelson, A.S.: Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation, Immunol. Today 14, 412–415 (1993).
  • [7] Kirschner D.: Using mathematics to understand HIV immune dynamics, AMS. Notices, 43, 191–202 (1996).
  • [8] Levy, J.A.: HIV and the pathogenesis of AIDS, Washington DC: ASM Press, 1994.
  • [9] Liu, W.M., Levin, S.A., Iwasa, Y.: Influence of nonlinear incidence rates upon the behavior of SIRS epidemiological models, J. Math. Biol. 23, 187–204 (1986).
  • [10] Martin R.H., Jr.: Logarithmic norms and projections applied to linear differential systems, J. Math. Anal. Appl. 45, 432–454 (1974).
  • [11] McLean, A.R., Rosado, M.M., Agenes, F., Vasconcellos, R., Freitas, A.A.: Resource competition as a mechanism for B cell homeostasis, Proc. Natl. Acad. Sci. USA 94, 5792–5797 (1997).
  • [12] Muldowney, J.S.: Dichotomies and asymptotic behaviour for linear differential systems, Trans. Amer. Math. Soc. 283, 465–584 (1984).
  • [13] Muldowney, J. S.: Compound matrices and ordinary differential equations, Rocky Mountain J. Math. 20, 857–872 (1990).
  • [14] Nowak, M.A., Bonhoeffer, S., Shaw, G.M., May, R.M.: Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations, J. Theor. Biol. 184, 203–217 (1997).
  • [15] Ouifki, R., Witten, G.: A model of HIV-1 infection with HAART therapy and intracellular delay, Discrete Cont. Dyn-B 8, 229–240 (2007).
  • [16] Percus, J.K., Percus, O.E., Perelson, A.S.: Predicting the size of the T-cell receptor and antibody combining region from consideration of efficient self-nonself discrimination, Proc. Natl. Acad. Sci. USA 90, 1691–1695 (1993).
  • [17] Perelson, A.S., Essunger, P., Cao, Y.: Decay characteristics of HIV-1-infected compartments during combination therapy, Nature 387, 188–191 (1997).
  • [18] Perelson, A.S., Nelson P.W.: Mathematical analysis of HIV-1 dynamics in vivo, SIAM Rev. 41, 3–44 (1999).
  • [19] Smith, H.L.: Monotone dynamical systems: An Introduction to the theory of competitive and cooperative systems, Trans. Amer. Math. Soc. vol. 41, 1995.
  • [20] Smith, H.L.: Systems of ordinary differential equations which generate an order preserving flow, SIAM Rev. 30, 87–98 (1998).
  • [21] Smith, H.L., Zhu, H.R.: Stable periodic orbits for a class of three-dimensional competitive systems, J. Differential Equations 110, 143–156 (1994).
  • [22] Song, X.Y. and Neumann A.U.: Global stability and periodic solution of the viral dynamics, J. Math. Anal. Appl. 329(1), 281–297 (2007).
  • [23] Srivastava P.K., Banerjee, M., Chandra, P.: Modeling the drug therapy for HIV infection, J. Biol. Syst. 17, 213–223 (2009).
  • [24] Srivastava, P.K., Chandra, P.: Modeling the dynamics of HIV and CD4+ T cells during primary infection, Nonlinear Anal. RWA 11, 612–618 (2010).
  • [25] Thieme, H.R.: Persistence under relaxed point-dissipativity (with applications to an endemic model), SIAMJ.Math. Anal. 24, 407–435 (1993).
  • [26] Zack, J.A., Arrigo, S.J., Weitsman, S.R., Go, A.S., Haislip A., Chen, I.S.: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile latent viral structure, Cell 61, 213–222 (1990).
  • [27] Zack, J.A., Haislip, A.M., Krogstad, P., Chen, I.S.: Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral cycle, J. Virol. 66, 1717–1725 (1992).
  • [28] Zandrea Ambrose, John G. Julias, Paul L. Boyer, Vineet N. KewalRamani, Stephen H. Hughes, The level of reverse transcriptase (RT) in human immunodeficiency virus type 1 particles affects susceptibility to nonnucleoside RT inhibitors but not to Lamivudine, J. Virol. 80, 2578–2581 (2006).
  • [29] Zhen, J., Haque M., Liu Q.X.: Pulse vaccination in the periodic infection rate SIR epidemic model, International Journal of Biomathematics 1, 409–432 (2008).
  • [30] Zhou, X.Y., Song X.Y., Shi, X.Y.: A differential equation model of HIV infection of CD4+ T-cells with cure rate, J. Math. Anal. Appl. 34, 1342–1355 (2008).